首页|HPV-DNA分型联合血清NLR、DCLK1对宫颈癌的早期诊断价值

HPV-DNA分型联合血清NLR、DCLK1对宫颈癌的早期诊断价值

扫码查看
目的 探讨人乳头瘤病毒(human papilloma virus,HPV)-DNA分型联合血清中性粒细胞-淋巴细胞比值(lymphocyte ratio,NLR)、双皮质素样激酶 1(bicorticoid kinase,DCLK1)水平对宫颈癌的早期诊断价值.方法 随机纳入 2018 年 8月至 2022 年 6 月在笔者医院妇科确诊的 120 例早期宫颈癌患者为宫颈癌组,120 例良性病变患者为良性组.采用ELISA法检测DCLK1 水平;采用自动血细胞分析仪检测NLR;采用HPV分型基因芯片检测系统检测宫颈分泌物的HPV亚型;采用受试者操作特征(receiver operator curve,ROC)曲线来分析血清NLR、DCLK1 水平诊断宫颈癌的截断值;采用四表格分析HPV-DNA分型、血清NLR、DCLK1 水平单独及联合对宫颈癌的诊断价值.结果 与良性组相比,宫颈癌组血清NLR、DCLK1 水平显著升高(P<0.05).宫颈癌组的各类型HR-HPV阳性率均显著高于良性组(P<0.05).以血清NLR、DCLK1 水平为检验变量绘制ROC曲线,血清NLR、DCLK1 预测早期宫颈癌的曲线下面积(area under curve,AUC)分别为 0.724、0.718,截断值分别为 3.08、3.32.HPV-DNA分型联合血清NLR、DCLK1 检出假阳性 18 例,假阴性 17例,Kappa值为 0.725,与病理结果一致性较高.HPV-DNA分型联合血清NLR、DCLK1 水平诊断早期宫颈癌的敏感度、阴性预测值及准确度均明显高于HPV-DNA分型、血清NLR、DCLK1 水平单独诊断(P<0.05).结论 HPV-DNA分型联合NLR、DCLK1 对早期宫颈癌的诊断结果与病理结果具有较高的一致性,且敏感度、准确度明显提高.
Diagnostic value of HPV-DNA typing combined with serum NLR and DCLK1 for cervical cancer
Objective To investigate the value of receiver operating curve human papilloma virus(HPV)-DNA typing combined with serum neutrophil lymphocyte ratio(NLR)and bicorticoid kinase 1(DCLK1)levels in the early diagnosis of cervical cancer.Methods A total of 120 patients with early cervical cancer diagnosed in our obstetrics and gynecology department from August 2018 to June 2022 were randomly included as cervical cancer group,and 120 patients with benign lesions were included as benign group.The level of DCLK1 was detected by ELISA;NLR was detected by automatic blood cell analyzer;HPV subtypes in cervical secretions were detected by HPV genotyping gene chip detection system;the cut-off values of serum NLR and DCLK1 levels in the diagnosis of cervical cancer were analyzed by using the receiver operator curve(ROC);four table method was applied to analyze the diagnostic value of HPV-DNA typing,serum NLR,DCLK1 levels alone and in combination for cervical cancer.Results Compared with benign group,the levels of serum NLR and DCLK1 in cervical cancer group were obviously higher(P<0.05).The positive rate of HR-HPV in cervical cancer group was obviously higher than that in benign group(P<0.05).The ROC curve was drawn with serum NLR and DCLK1 levels as test variables,the results showed that the AUC of serum NLR and DCLK1 predicting early cervical cancer was 0.724 and 0.718,respectively,and the cut-off value was 3.08 and 3.32,respectively.HPV-DNA typing combined with serum NLR and DCLK1 detected 18 false positives and 17 false negatives,Kappa value was 0.725,which was consistent with pathological results.The sensitivity,negative predictive value and accuracy of HPV-DNA typing combined with serum NLR and DCLK1 levels in the diagnosis of early cervical cancer were obviously higher than those of HPV-DNA typing,serum NLR and DCLK1 levels alone(P<0.05).Conclusion The results of HPV-DNA typing combined with NLR and DCLK1 in the diagnosis of early cervical cancer are highly consistent with the pathological results,and the sensitivity and accuracy are obviously improved.

Cervical cancerNeutrophils/lymphocytesDoublecortin like kinase 1HPV-DNA typingDiagnosis

倪红妙、曾慧、丁利胜

展开 >

杭州市第九人民医院检验科,浙江杭州 311225

宫颈癌 中性粒细胞/淋巴细胞 双皮质素样激酶1 HPV-DNA分型 诊断

浙江省医药卫生科技计划

2019KY549

2024

中国现代医生
中国医学科学院

中国现代医生

影响因子:1.571
ISSN:1673-9701
年,卷(期):2024.62(8)
  • 25